We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Atreca

News List

Atreca Appoints Stacey Ma and Stephen Brady to its Board of Directors firstwordpharma
July 20, 2021
Atreca today announced the appointment of Dr. Stacey Ma, Executive Vice President and Head of Technical Operations at Sana Biotechnology, and Stephen R. Brady, Chief Executive Officer of Tempest Therapeutics, to its Board of Directors.
Atreca bags $125M as solid tumor trial comes into view fiercebiotech
September 13, 2018
Atreca’s cranking of its discovery engine has uncovered more than 1,000 antibodies.
Big Pharma ally Atreca scoops $35M as I-O assets near IND fiercebiotech
August 18, 2017
Atreca plans to pick a clinical candidate by the end of the year.